Literature DB >> 11797074

Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers.

S K Min1, I W Moon, R W Ko, H S Shin.   

Abstract

RATIONALE: Nicotine has been found to improve cognitive functions in patients with Alzheimer's disease, but little is known about its effects in the healthy non-smoking elderly.
OBJECTIVES: This study aimed to investigate the effects of nicotine on cognitive function in healthy non-smoking or nicotine-naïve elderly subjects.
METHODS: A transdermal patch containing either 5 mg nicotine or placebo was applied on the back of 63 healthy nicotine-naïve or non-smoking elderly Koreans. Cognitive functions were evaluated with the Short Blessed Test, Rey-Kim Memory Test, and digit span test of the Korean-WAIS, both before and 5.5 h after nicotine administration. The plasma level of nicotine after testing was measured using gas chromatography.
RESULTS: The subjects' memory functions in trial 5 of the Rey-Kim Memory Tests improved significantly. Furthermore, the effect on memory slope was significantly correlated with the higher plasma level of nicotine. However, the other tests did not reveal any correlation to a significant degree.
CONCLUSIONS: These results suggest that nicotine of lower plasma level can improve short-term verbal memory functions in non-smoking or nicotine-naïve healthy elderly people and that some effects are dependent on nicotine plasma levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797074     DOI: 10.1007/s002130100899

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Nicotine modulates human brain plasticity via calcium-dependent mechanisms.

Authors:  Jessica Grundey; Jerick Barlay; Giorgi Batsikadze; Min-Fang Kuo; Walter Paulus; Michael Nitsche
Journal:  J Physiol       Date:  2018-10-17       Impact factor: 5.182

Review 2.  Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

Review 3.  Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.

Authors:  Kristi A Sacco; Katie L Bannon; Tony P George
Journal:  J Psychopharmacol       Date:  2004-12       Impact factor: 4.153

Review 4.  Cholinergic modulation of the hippocampal region and memory function.

Authors:  Juhee Haam; Jerrel L Yakel
Journal:  J Neurochem       Date:  2017-08       Impact factor: 5.372

5.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

Review 6.  Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.

Authors:  Alvin V Terry; Patrick M Callahan; Caterina M Hernandez
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

7.  Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment.

Authors:  Heidi K White; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2003-10-08       Impact factor: 4.530

8.  Nicotinic receptors in neurodegeneration.

Authors:  Inmaculada Posadas; Beatriz López-Hernández; Valentín Ceña
Journal:  Curr Neuropharmacol       Date:  2013-05       Impact factor: 7.363

9.  Task-dependent effects of nicotine treatment on auditory performance in young-adult and elderly human nonsmokers.

Authors:  Shuping Sun; Michelle R Kapolowicz; Matthew Richardson; Raju Metherate; Fan-Gang Zeng
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.996

10.  Clinical observation of 12 farmers who believe themselves to have suffered from chronic pesticide intoxication.

Authors:  Zoong-Rock Hong; So-Young Hong; Mi-Jung Han; Hae-seung Lee; Hyo-Ook Gil; Jong-O Yang; En-Yung Lee; Sae-Yong Hong
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.